Albert Robichaud, Chief Scientific Officer at Sage Therapeutics, Inc. (SAGE), sold 22,000 shares at $40.00 ($880K) on 2016-07-12, disclosed to the SEC on 2016-07-14.
Open-market sale of $880k SAGE by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SAGE | SELL | 2016-01-26 | $1.6M | — | Filing → |
| SAGE | SELL | 2015-08-04 | $805K | — | Filing → |
| SAGE | SELL | 2015-07-01 | $1.2M | — | Filing → |